These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16359856)

  • 21. Loss of p63 expression is associated with tumor progression in bladder cancer.
    Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
    Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
    Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
    Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63 is a p53 homologue required for limb and epidermal morphogenesis.
    Mills AA; Zheng B; Wang XJ; Vogel H; Roop DR; Bradley A
    Nature; 1999 Apr; 398(6729):708-13. PubMed ID: 10227293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of vitamin D receptor as a target of p63.
    Kommagani R; Caserta TM; Kadakia MP
    Oncogene; 2006 Jun; 25(26):3745-51. PubMed ID: 16462763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer.
    Wu G; Osada M; Guo Z; Fomenkov A; Begum S; Zhao M; Upadhyay S; Xing M; Wu F; Moon C; Westra WH; Koch WM; Mantovani R; Califano JA; Ratovitski E; Sidransky D; Trink B
    Cancer Res; 2005 Feb; 65(3):758-66. PubMed ID: 15705872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
    Venkatanarayan A; Raulji P; Norton W; Flores ER
    Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 family update: p73 and p63 develop their own identities.
    Irwin MS; Kaelin WG
    Cell Growth Differ; 2001 Jul; 12(7):337-49. PubMed ID: 11457731
    [No Abstract]   [Full Text] [Related]  

  • 31. p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis.
    King KE; Weinberg WC
    Mol Carcinog; 2007 Aug; 46(8):716-24. PubMed ID: 17477357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p63 expression pattern in foetal and neonatal gonocytes after irradiation and role in the resulting apoptosis by using p63 knockout mice.
    Petre-Lazar B; Moreno SG; Livera G; Duquenne C; Habert R; Coffigny H
    Int J Radiat Biol; 2006 Nov; 82(11):771-80. PubMed ID: 17148261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p19ras brings a new twist to the regulation of p73 by Mdm2.
    Harms KL; Chen X
    Sci STKE; 2006 May; 2006(337):pe24. PubMed ID: 16738062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.
    Evan GI; Christophorou M; Lawlor EA; Ringshausen I; Prescott J; Dansen T; Finch A; Martins C; Murphy D
    Cold Spring Harb Symp Quant Biol; 2005; 70():263-73. PubMed ID: 16869762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
    Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K
    Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogene activation and tumor suppressor gene inactivation find their sites of expression in the changes in time and space of the age-adjusted cancer incidence rate.
    Kodama M; Kodama T; Murakami M
    In Vivo; 2000; 14(6):725-34. PubMed ID: 11204489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult mice lacking the p53/p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndromes.
    Ihrie RA; Bronson RT; Attardi LD
    Cell Death Differ; 2006 Sep; 13(9):1614-8. PubMed ID: 16485031
    [No Abstract]   [Full Text] [Related]  

  • 39. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.
    Adorno M; Cordenonsi M; Montagner M; Dupont S; Wong C; Hann B; Solari A; Bobisse S; Rondina MB; Guzzardo V; Parenti AR; Rosato A; Bicciato S; Balmain A; Piccolo S
    Cell; 2009 Apr; 137(1):87-98. PubMed ID: 19345189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner.
    Lee HO; Lee JH; Choi E; Seol JY; Yun Y; Lee H
    Biochem Biophys Res Commun; 2006 May; 344(1):166-72. PubMed ID: 16616891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.